Overall, it is clear that viral infection modulates the phenotype of the novel DN3 subset such that these cells have reduced BAFFR and CD86 but elevated levels of FcRL5, CD22, and CD69 during severe disease. This evidence concerns the gene CD86 and viral infectious disease.